Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Roguin

Showing results (221-230 of 283) with videos related to

Pageof 29
Sort By:
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 18, 2017
BIOFLOW-III satellite-One-year clinical outcomes of diabetic patients treated with a biodegradable polymer sirolimus-eluting stent and comprehensive medical surveillanceRan Kornowski, Ariel Roguin, Haim Danenberg, et al.
Diabetes Care|August 28, 2003
Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarctionMahmoud Suleiman, Michael R Kapeliovich, Ariel Roguin, et al.
Circulation. Heart Failure|May 12, 2011
TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failureZaid A Abassi, Yaron D Barac, Sawa Kostin, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER RegistryYaniv Levi, Ofer Kobo, Majdi Halabi, et al.
Cardiovascular Diabetology|December 20, 2003
Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb modelAriel Roguin, Samy Nitecki, Irit Rubinstein, et al.
Circulation|July 28, 2004
Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 TAriel Roguin, Menekhem M Zviman, Glenn R Meininger, et al.
The American Journal of Cardiology|November 1, 2019
Optimal Timing for Coronary Intervention in Patients With Transient ST-Elevation Myocardial InfarctionSimcha R Meisel, Michael Kleiner-Shochat, Rami Abu Fanne, et al.
Journal of the American College of Cardiology|May 18, 2004
Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathyAriel Roguin, Chandra S Bomma, Khurram Nasir, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Primary percutaneous coronary intervention after out-of-hospital cardiac arrest: patients and outcomesErez Marcusohn, Erez Markusohn, Ariel Roguin, et al.
Journal of the American Heart Association|December 3, 2019
Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster RegistryPablo Codner, Majdi Saada, Orazbek Sakhov, et al.
Pageof 29

Showing results (221-230 of 283) with videos related to

Sort By:
Pageof 29
Cardiovascular Revascularization Medicine : Including Molecular Interventions|March 18, 2017
BIOFLOW-III satellite-One-year clinical outcomes of diabetic patients treated with a biodegradable polymer sirolimus-eluting stent and comprehensive medical surveillanceRan Kornowski, Ariel Roguin, Haim Danenberg, et al.
Diabetes Care|August 28, 2003
Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarctionMahmoud Suleiman, Michael R Kapeliovich, Ariel Roguin, et al.
Circulation. Heart Failure|May 12, 2011
TVP1022 attenuates cardiac remodeling and kidney dysfunction in experimental volume overload-induced congestive heart failureZaid A Abassi, Yaron D Barac, Sawa Kostin, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Treatment of Ostial Right Coronary Artery Narrowings: Outcomes From the Multicenter Prospective e-ULTIMASTER RegistryYaniv Levi, Ofer Kobo, Majdi Halabi, et al.
Cardiovascular Diabetology|December 20, 2003
Vascular endothelial growth factor (VEGF) fails to improve blood flow and to promote collateralization in a diabetic mouse ischemic hindlimb modelAriel Roguin, Samy Nitecki, Irit Rubinstein, et al.
Circulation|July 28, 2004
Modern pacemaker and implantable cardioverter/defibrillator systems can be magnetic resonance imaging safe: in vitro and in vivo assessment of safety and function at 1.5 TAriel Roguin, Menekhem M Zviman, Glenn R Meininger, et al.
The American Journal of Cardiology|November 1, 2019
Optimal Timing for Coronary Intervention in Patients With Transient ST-Elevation Myocardial InfarctionSimcha R Meisel, Michael Kleiner-Shochat, Rami Abu Fanne, et al.
Journal of the American College of Cardiology|May 18, 2004
Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathyAriel Roguin, Chandra S Bomma, Khurram Nasir, et al.
The Israel Medical Association Journal : IMAJ|May 12, 2007
Primary percutaneous coronary intervention after out-of-hospital cardiac arrest: patients and outcomesErez Marcusohn, Erez Markusohn, Ariel Roguin, et al.
Journal of the American Heart Association|December 3, 2019
Proximal Left Anterior Descending Artery Treatment Using a Bioresorbable Polymer Coating Sirolimus-Eluting Stent: Real-World Outcomes From the Multicenter Prospective e-Ultimaster RegistryPablo Codner, Majdi Saada, Orazbek Sakhov, et al.
Pageof 29